Immune checkpoints mediate immunosuppressive effects on T-cell responses; the best-studied checkpoint in AML is the T-cell expressed PD-1 (programmed cell death 1) and its ligand PD-L1 [27,28]. The gene discussed is PDCD1; the disease is acute myeloid leukemia.